Global Financial Private Client LLC boosted its position in shares of Gilead Sciences, Inc. (NASDAQ:GILD - Free Report) by 1,222.0% in the fourth quarter, according to its most recent filing with the Securities & Exchange Commission. The fund owned 6,068 shares of the biopharmaceutical company'